ABSTRACT
Background A few studies have found a connection between body mass index (BMI) and blood pressure (BP), which may contribute to people’s health issues. A person who has a BMI greater than what is considered healthy for their height to weight ratio is more likely to have high blood pressure, which increases their risk for conditions including type 2 diabetes, gallstones, respiratory issues, and some types of cancer. Understanding the relationship between blood pressure and body mass index is crucial.
Aim The overall goal of this review is to provide evidence on a correlative study of blood pressure and BMI in the United Kingdom.
Methods A literature search was conducted on PsycINFO, PubMed, Web of Science, Science Direct, and Cochrane Library to identify studies addressing the primary research question. The participants for this study were individuals in the United Kingdom aged 18 years and above. The study considered studies published from 2000–2022 and quantitative studies as well as mixed-method studies. The critical appraisal risk of bias tool was used to determine the quality assessment of the studies included in this systematic review.
Results 27,322 participants were involved from a total of seven eligible studies were identified from the hits. The overall pooled correlation of body mass index and blood pressure in the United Kingdom was 0.6, demonstrating that there is a correlation between the variables. From three of the studies, a correlation between body mass index (Kg/m2) and systolic blood pressure (mmHg) across the participants was noted (n = 27,322, SD: 21.4; r = 0.6, p>0.000).
Conclusion Body mass index and blood pressure are strongly correlated in both the general population and tens of thousands of subgroups, suggesting that almost all demographic groups in the UK are affected by the growth in hypertension prevalence. In light of the estimates of the potential associations between body mass index, stroke, and ischemic heart disease based on the current pattern of treatment in this population, the UK and other nations going through a similar epidemiologic transition should be persuaded to address the rising prevalence of hypertension as a national priority.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
